Summit Therapeutics Inc.

SMMT · Nasdaq · SIC 2834: Pharmaceutical Preparations
274
SEC Filings

Business Summary

Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of oncology therapies. Its lead product candidate is ivonescimab, a novel bispecific antibody combining PD-1 immunotherapy blockade with anti-VEGF anti-angiogenesis effects into a single molecule. The company in-licensed ivonescimab from Akeso, Inc. in December 2022 and is pursuing clinical development including a BLA accepted for filing related to the HARMONi study.

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSMMTdiscussed_in_filing Cybersecurity
topic_mentionSMMTdiscussed_in_filing Trusted Computing
topic_mentionSMMTdiscussed_in_filing Blockchain & Crypto
topic_mentionSMMTdiscussed_in_filing Supply Chain
topic_mentionSMMTdiscussed_in_filing Regulation
topic_mentionSMMTdiscussed_in_filing Healthcare & Bio
topic_mentionSMMTdiscussed_in_filing Sovereign & Government
topic_mentionSMMTdiscussed_in_filing Cybersecurity
topic_mentionSMMTdiscussed_in_filing Trusted Computing
topic_mentionSMMTdiscussed_in_filing Blockchain & Crypto
topic_mentionSMMTdiscussed_in_filing Supply Chain
topic_mentionSMMTdiscussed_in_filing Regulation
topic_mentionSMMTdiscussed_in_filing Healthcare & Bio
topic_mentionSMMTdiscussed_in_filing Sovereign & Government
topic_mentionSMMTdiscussed_in_filing Cybersecurity
topic_mentionSMMTdiscussed_in_filing Trusted Computing
topic_mentionSMMTdiscussed_in_filing Blockchain & Crypto
topic_mentionSMMTdiscussed_in_filing Supply Chain
topic_mentionSMMTdiscussed_in_filing Regulation
topic_mentionSMMTdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-232025-12-310001599298-26-000015EDGAR89K words
2025-02-242024-12-310001599298-25-000048EDGAR—
2024-02-202023-12-310001599298-24-000031EDGAR—
2023-03-092022-12-310001599298-23-000034EDGAR—
2022-03-172021-12-310001599298-22-000032EDGAR—
2021-03-312020-12-310001599298-21-000011EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-202025-09-300001599298-25-000159EDGAR23K words
2025-08-112025-06-300001599298-25-000126EDGAR—
2025-05-012025-03-310001599298-25-000089EDGAR—
2024-10-302024-09-300001599298-24-000158EDGAR—
2024-08-062024-06-300001599298-24-000117EDGAR—
2024-05-012024-03-310001599298-24-000085EDGAR—
2023-11-072023-09-300001599298-23-000098EDGAR—
2023-08-092023-06-300001599298-23-000077EDGAR—
2023-05-112023-03-310001599298-23-000054EDGAR—
2022-11-092022-09-300001599298-22-000118EDGAR—
2022-08-112022-06-300001599298-22-000095EDGAR—
2022-05-112022-03-310001599298-22-000044EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-230001599298-26-000014EDGAR4K words
2026-01-290001599298-26-000006EDGAR—
2026-01-120001599298-26-000004EDGAR—
2025-11-070001599298-25-000166EDGAR—
2025-10-220001193125-25-245790EDGAR—
2025-10-200001599298-25-000156EDGAR—
2025-09-080001599298-25-000137EDGAR—
2025-08-110001599298-25-000128EDGAR—
2025-08-110001193125-25-178022EDGAR—
2025-06-200001599298-25-000120EDGAR—

274 total filings indexed. 246 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology biopharmaceuticals

Company Identity

CIK0001599298
TickerSMMT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 5d44c08c4d49855a29e90974f99313825c182437f8a5e019ff9262c7896b30df
parent: c5d5dd999093c1a212579cb82090891fb7556243a0211326ba1ef1679341f67c
content hash: a800da8a7bb1b8cac4c75cdcafe94817b6a270e58d58e44a92251a809c1cb3a7
signed: 2026-04-13T04:47:30.082Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf